Liver fibrosis and hepatic stellate cells: etiology, pathological hallmarks and therapeutic targets
In traditional therapies, the body may shift into an "efficiency mode" where responsiveness levels off
Sergey Terushkin, MD, FACS, provides Philadelphia, Pennsylvania, and New Jersey residents with: Whether you live in Philly or anywhere in PA/NJ, you can start treatment with a simple online visit
542 identified JMJD3 as one of the main drivers of esophageal squamous cell carcinoma pathogenesis through JMJD3/MYC/miR-1792 pathway and regulate stemness and sensitivity to therapy
The cells' overall defense systems are essentially collapsing under the weight of the inflammation, leading to mitochondrial calcium overload and eventual energy failure
Patients with significant pre-existing gastrointestinal conditions should be carefully evaluated by their provider before initiating therapy